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12 Peanut allergy (PA) is a common, potentially life-threatening, and typically lifelong condition with a 
13 significant burden of illness. However, information is lacking on how persons with PA (PwPA) and 
14 their caregivers perceive the psychosocial impact of living with PA. The Allergy to Peanuts imPacting 
15 Emotions And Life study 1 (APPEAL-1) survey, conducted across Europe, investigated the 
16 experience and impact of living with PA. Here, we report data evaluating the psychosocial impact of 
17 PA on PwPA and their caregivers.
18 Methods
19 APPEAL-1 was an online survey conducted in 8 European countries. Representatives of 8 patient 
20 advocacy groups and 5 healthcare-research specialists developed the survey. Eligible respondent 
21 groups included: adults diagnosed with PA (self-report); parent/nonparent caregivers (proxy-report for 
22 a child with PA); and parent/nonparent caregivers (self-report of PA impact on themselves). 
23 Results
24 Of 1846 total study respondents, 419 were adults with PA (self-report); 546 were parents/ caregivers 
25 (proxy-report) ; 881 were parents/caregivers (self-report). Most respondents reported lifestyle 
26 restrictions regarding food (84-93%) and additional domains including parties and socializing, holiday 
27 activities and destinations, and taking public transport (53-89%). Approximately 40% rated 
28 themselves as “very” frustrated and “very” stressed. Two-thirds (65%) felt socially isolated; 43% 
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1 intercountry differences were observed such as high levels of uncertainty and stress in respondents 
2 from Ireland, highest rates of anxiety in respondents from Germany, and social exclusion and 
3 isolation most common in respondents from France. 
4 Conclusions
5 PA imposes an adverse psychosocial impact on patients and caregivers, leading to frustration, stress, 
6 and isolation. Attention to the impact of PA is needed in research and clinical practice to improve PA 
7 healthcare and public education programs. 
8
9
10 Keywords: Bullying, coping, daily life, peanut allergy, psychosocial impacts. 
11 INTRODUCTION
12 Peanut allergy (PA) is typically a lifelong and potentially life-threatening condition with an estimated 
13 prevalence of up to 2.8% of the general population in Europe.1-3 A 2- to 3-fold increase in diagnosed 
14 PA over the last 2-3 decades has also been reported in the UK and US, although the reasons behind 
15 these rising prevalence rates remain unclear.4,5 In most cases, PA persists into adulthood,6-9 while 
16 allergies to milk, egg, wheat, and soy often resolve during childhood.1 PA is also associated with 
17 higher rates of accidental exposures, severe reactions, and anaphylaxis than are other food allergies.10-
18 16 Most persons with PA (PwPA) have one or more comorbid nonfood atopic diseases (e.g. atopic 
19 dermatitis, asthma) and/or other food allergies.17,18 
20
21 Standard of care for PA is the avoidance of peanut and use of rescue medication in cases of accidental 
22 exposures.19-21 However, dietary avoidance itself can be a major source of anxiety, stress, uncertainty, 
23 and activity restrictions.22-24 When allergic reactions occur, those having the reaction, parents, and 
24 healthcare professionals (HCPs) tend to underutilise adrenaline autoinjectors (AAIs)25-28 in part 
25 because of confusion and misconceptions on exactly how and when they should be used.26,29 This 
26 reinforces uncertainty regarding correct management, increases stress and may substantially impair 
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1 Although previous studies have shown that PA adversely impacts HRQL for PwPA and the 
2 parents/caregivers of children with PA,20,22,31-33 many questions remain. These include understanding 
3 how individuals and families experience daily life with this condition and how they perceive current 
4 healthcare management of PA. Furthermore, there is little research on the psychosocial factors 
5 impacting HRQL associated with PA. Individual countries may have varying prevalence and 
6 awareness of PA, differing social attitudes towards it, and varying support systems for PwPA, in 
7 addition to the variety of healthcare systems across countries that can influence care for PwPA. These 
8 factors suggest that potentially important differences may exist in the impact of PA across countries 
9 and should be investigated. 
10
11 The APPEAL-1 (Allergy to Peanuts ImPacting Emotions And Life 1) study was conducted to 
12 comprehensively assess the impact of living with PA on caregivers and PwPA across 8 countries in 
13 Europe. In this second of two articles describing the results of APPEAL-1, we report data collected 
14 directly to understand the psychosocial and HRQL impact of PA on PwPA and their caregivers. The 
15 data relating to the circumstances of diagnosis, severity of symptoms, comorbidities, management, 
16 and other clinical factors captured by APPEAL-1 are reported in an independent article published in 




21 The design and methods used in developing the APPEAL-1 study and the survey are fully described 
22 in a companion paper appearing in this issue of Allergy. In brief, APPEAL-1 is a quantitative, cross-
23 sectional, multidimensional, online survey study conducted in 8 European countries (Denmark, 
24 France, Germany, Ireland, Italy, the Netherlands, Spain, and the UK). The question items that make 
25 up the survey address key areas of concern (refer to survey format below) for PwPA and their 
26 caregivers, based on previous research in the field. Given that the range of topics planned for this 
27 study (from symptoms through to bullying and daily management) was far wider than is captured by 
28 any existing measure quality-of-life measure, it was decided to develop a novel, study-specific survey 
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1 that goals and questions for this survey instrument were relevant. Representatives of 8 patient 
2 advocacy groups (PAGs) and a specialist panel, comprised of a mix of 5 specialists from various 
3 healthcare research fields, collaborated to develop the study and the questionnaire. The 30-minute 
4 survey was originally written in English and translated/back-translated into 6 other languages, 
5 including Danish, Dutch, French, German, Italian, and Spanish; all language versions were reviewed 
6 by the PAG representatives and piloted in test respondent samples. Ethical approval for this study was 




11 Participants were recruited via the PAGs or through a professional recruitment service for research 
12 studies. Two categories of participants reported on their own behalf (self-report): (i) adults with PA, 
13 and (ii) parent and nonparent caregivers who reported the impact of PA on themselves as caregivers. 
14 With regard to category ii, these parents/caregivers, hereafter referred to in this report as “caregivers”, 
15 were also invited to report the impact of PA on behalf of the individual for whom they were caring 
16 (proxy-report). Therefore, the total number of respondents exceeded the total number of participants. 
17
18 Study inclusion/exclusion criteria
19 Requirements for respondents recruited via PAGs:
20  self- or caregiver-reported diagnosis of PA, 
21  18 years of age or older,
22  resident of one of the 8 designated countries, and
23  able to provide informed consent, by self or by caregiver/proxy. 
24 Exclusions for respondents recruited via the professional recruitment service:
25  Participation in a market research study of PA during the previous 2 months
26  Membership in a PAG 
27
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1 The survey consisted of questions in 4 main sections: (1) screening/inclusion criteria; (2) PA 
2 respondent characteristics and clinical history, including PA diagnosis and allergic reaction history, 
3 other concomitant allergies and medical conditions, and use of emergency medication; (3) 
4 psychosocial impact of PA (restrictions on choice, coping with/managing PA, relating to others, 
5 feelings and emotions); and (4) respondent sociodemographic information. The results for sections 2 
6 (clinical history/characteristics) and 4 (sociodemographic data) are summarised in the paired report, 
7 which appears in this issue of Allergy. In section 3, in addition to rating their responses on a 5-point 
8 scale, respondents were given the opportunity to add free-text comments. 
9
10 Data analysis
11 Demographic, clinical, and survey response data were reported with descriptive statistics. Data were 
12 assessed with regard to: (1) total population (i.e. all countries and all respondent types); (2) individual 
13 country; and (3) respondent type (adults with PA [self-report], children with PA [proxy-report by 
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1 RESULTS
2 Survey respondent population
3 The total study population was 1846 respondents, comprising 419 adults with PA (self-report), 546 
4 caregivers who answered for the child with PA (caregiver proxy-report), and 881 caregivers of a child 
5 with PA, who answered regarding the impact of PA on themselves. The demographic and clinical 
6 characteristics and PA history of the study population are described in the companion report in this 
7 issue of Allergy. 
8
9 Impacts of PA on psychosocial parameters and quality of life
10 Restrictions on choice 
11 Restrictions on choice were reported by respondents in a wide range of contexts using a scale of “not 
12 at all,” “a little,” “moderately,” “very,” or “extremely” restricted and “don’t know/not applicable.” 
13 Most respondents reported that they felt restricted (rating ≥2) in choosing: where to eat out (89%, 
14 including who felt 58% “very” or “extremely” restricted); food options when eating out (94%; 62% 
15 “very” or “extremely”); shops where they can buy food (79%; 29% “very” or “extremely”); and 
16 buying food (84%; 38% “very” or “extremely”) (Figure 1). Furthermore, respondents reported that 
17 they felt restricted in choices not directly related to food, such as choice of schools (55%), job options 
18 (37%), socialising (75%), and going to special occasions (89%) (Figure 1). A large majority (87%) 
19 said extra planning was needed for managing PA for “daily activities” and 89% said extra planning 
20 was needed for “special activities”. When asked to rate their HRQL because of having to make extra 
21 plans, on a scale of 1 to 5 (where 1=excellent and 5=poor)34, only 16% rated it as “excellent,” 
22 although even fewer (3%) rated it “poor.” Examples of the need for planning for PA as described by 
23 respondents are given in Table 1. 
24
25 Feelings and emotions
26 The psychological impact of PA was clearly evident in our findings. Respondents reported 
27 experiencing negative feelings and emotions due to the impact of PA on their lives on of 1 (“not at 
28 all,” “rarely,” or “extremely low”) to 5 (“very” or “extremely”). Large majorities of respondents 
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1 “extremely frustrated” due to living with PA.With regard to frequency of these feelings, 91% of 
2 respondents were at least “somewhat frequently” frustrated (14% “very frequently”). Many 
3 respondents (89%) also stated they felt at least “some” uncertainty, and 90% reported feeling stress, 
4 with 40% at the upper end of the scale (i.e. scores of 4 or 5) for uncertainty and stress. Anxiety played 
5 a central role in the lives of a great number of respondents, with more than one-third of respondents 
6 reporting that they frequently (score of 4 or 5) felt anxious (36%) or frequently felt tense (30%). Only 
7 one-third (34%) rarely felt that “nothing bad will happen”; 30% stated they rarely felt calm (i.e. scores 
8 of 1 or 2). 
9
10 With regard to specific contexts or settings, 92% of respondents said they worry about exposure to 
11 peanut on social occasions where food is involved, and more than half (54%) worry during occasions 
12 where food is not involved. Respondents worried about exposure to peanut in multiple other settings 
13 including at school/college/university (71%); on holiday (84%); on public transport (58%); and at 
14 hospital (60%). 
15
16 Exclusion, isolation and bullying due to PA
17 Difference, isolation, exclusion and bullying are feelings and behaviours that are part of everyday life 
18 for PwPA. More than three-quarters of respondents (77%) reported they had “been made to feel 
19 different” (“frequently” to “rarely”) in a negative way because of PA, with 35% experiencing this 
20 frequently. Approximately two-thirds (65%) had experienced general feelings of isolation (23% 
21 “quite” or “very” frequently). Almost half of respondents (43%) said they had been excluded from 
22 social occasions where food was involved; 13% reported exclusion even where food was not involved 
23 (Figure 2). Of those who had been bullied (n=558; 43% of respondents), 10% said they experienced 
24 this behaviour frequently. Approximately one-third of respondents (both self- and proxy-reporting) 
25 described the impact of the bullying as severe (score of 4 or 5 on a 5-point scale) (Figure 3). A 
26 representative description of the social restrictions and impacts caused by PA is given in Quote 2 in 
27 Table 1. 
28
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1 The psychological impacts of PA presented above can influence the subjective experience of living 
2 with a condition, which can have a significant impact on psychological adjustment or coping and a 
3 major impact on chronic disease health outcomes.35 Almost half of all respondents (45%) said they 
4 did not cope well when PA was first diagnosed (score of 4 or 5, where 1 is “extremely well” and 5 is 
5 “not at all well”) (Figure 4). However, three-quarters of respondents (74%) said they now cope well 
6 with PA compared to how they did at diagnosis (score of 1 or 2) (Figure 4), implying an 
7 improvement over time in coping ability. Two-thirds of respondents (65%) said they were confident 
8 (score of 1 or 2, where 1 is “extremely confident”) in their ability to recognise the symptoms of an 
9 allergic reaction, and 72% reported confidence in their ability to describe their symptoms to an HCP. 
10 However, rates of confidence were lower for knowing when to use an AAI (45%) and how to use one 
11 (59%). Potentially related to this finding, 87% worried about not having access to emergency services 
12 in case of peanut exposure. While 70% “would feel more anxious if they forgot to carry the AAI,” 
13 62% reported carrying their AAI with them “all the time.” Quote 3 in Table 1 describes a typical 
14 planning regimen for people with PA. 
15
16 Understanding of PA among family, friends, and others 
17 Public knowledge and attitudes, sociocultural values, and interpersonal relationships are known to 
18 impact HRQL in chronic disease.36 Respondents were asked to rate statements about how their family, 
19 friends, and other people understand and perceive an individual’s PA, on a scale of 1 (“most true”) to 
20 5 (“least true”) (Figure 5). Respondents gave both family and friends a mean score of “most true” for 
21 “They have good awareness and understanding of peanut allergy,” but said this was “least true” for 
22 other people. In scoring for “They tend to be oblivious about the dangers of peanut allergy,” 
23 respondents said this was “most true” of friends and other people. Yet respondents gave all categories 
24 of people (family, friends, other people) similar, moderate scores for “They feel awkward when 
25 making allowances for peanut allergy” and “They believe there is too much concern over peanut 
26 allergy.” These findings are likely to reflect different categories of friends.
27
28 Respondents stated that they found it easiest (“always” easy) to discuss the impact of living with PA 
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1 respondents stated they “rarely,” “very rarely,” or did not find it easy to discuss the impact of living 
2 with PA with their family, and 30% said they “rarely,” “very rarely,” or did not feel that way towards 
3 their friends (Figure 6). Only 5% of respondents said they were not at all confident when talking to 
4 new people about their PA, while 65% were either very confident (27%) or extremely confident 
5 (38%). Respondents gave both family and friends a mean score of “most true” for “They have good 
6 awareness and understanding of peanut allergy,” but said this was “least true” for other people. In 
7 scoring for “They tend to be oblivious about the dangers of peanut allergy,” respondents said this was 
8 “most true” of friends and other people. These findings suggest that although they are confident in 
9 their knowledge of PA and thus can discuss it if required, respondents were reluctant to do so, perhaps 
10 because of uncertainty about public attitudes (in general) to PA.37 Quote 4 in Table 1 briefly 
11 illustrates the kind of experience that people with PA and their caregivers may have with others. 
12
13 Intercountry comparisons
14 Although findings may reflect a response bias as well as differences in the recruiting process (e.g. age 
15 of respondents, recruitment through PAG versus the professional recruitment service), there were 
16 some differences in the patterns of responses among countries. In terms of reported restrictions on 
17 activities, the proportion of respondents found to have a “high level” of uncertainty and a “high level” 
18 of stress in Ireland (61% and 54%, respectively) was almost twice that of the Netherlands (31% and 
19 26%, respectively). Respondents in Germany had the highest rates of frequently feeling anxious and 
20 rarely feeling calm (52% and 44%, respectively), while the Netherlands had the lowest rates for these 
21 responses (16% and 13%, respectively). 
22
23 In Germany, 90% reported at least some restrictions for socialising and 86% for choice of holiday 
24 destinations, compared with 69% and 71%, respectively, of respondents in Italy reporting these 
25 restrictions. Feelings of social exclusion and isolation were most common in France where 86% of 
26 respondents reported that they had been made to feel different in a negative way versus 66% in Italy, 
27 and 74% of respondents from France reported feelings of isolation versus only 44% in Denmark. 
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1 With regard to coping with PA at first diagnosis, more than one-quarter of respondents in Germany 
2 (29%) said they coped “not at all well” versus 9% of respondents in Denmark. The percentage of 
3 respondents who said they now cope “extremely well” with PA, compared to when it was first 
4 diagnosed, was highest in Denmark (55%) and lowest in Spain (20%). The Netherlands had the 
5 highest rates of respondents who were “extremely confident” in their ability to recognise allergic 
6 reaction symptoms (39%) and in knowing when and how to use an AAI (26% and 53%, respectively). 
7 In contrast, Germany had the lowest rates of respondents who were “extremely confident” in 
8 recognising allergic reaction symptoms (22%) and knowing when to use an AAI (12%, along with 
9 Denmark). France had the lowest rate of knowing how to use an AAI (14%). 
10
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1 DISCUSSION 
2 APPEAL-1 is the first multidimensional, pan-European online survey study specifically designed to 
3 uncover the psychosocial burden of PA on the lives of both individuals and their families. The study 
4 was designed to provide a comprehensive examination of psychosocial health and quality of life, 
5 including novel aspects of emotional functioning and impact due to the impact of PA (frustration, 
6 anxiety, stress, isolation, and uncertainty). Furthermore, our findings showed that the experience of 
7 being bullied was prevalent among both children, as indicated in previous studies in children with 
8 food allergies including PA, 38-40and adults. In addition to the biologically determined nature of PA 
9 itself, a variety of internal and external factors can influence the subjective patient and caregiver 
10 experience, which, in turn, can have a significant impact on coping outcomes.
11
12 Our findings showed that those living with PA not only face many restrictions on choice in their 
13 activities, but experience feelings of frustration, anxiety, stress, isolation, and uncertainty in their 
14 everyday lives. The APPEAL-1 findings are consistent with, and extend, our knowledge of the impact 
15 of food allergy in general and of PA in particular.22,23,32,33,41 The findings also reveal a high unmet 
16 need for greater support, information, and education for allergic individuals and for the general public 
17 in living with and managing PA, and food allergies in general. For example, 40% of respondents said 
18 that they live with a high level of uncertainty, and 36% said that they rarely or never experience “the 
19 feeling that nothing bad will happen.” Smaller sample and qualitative studies have previously shown 
20 that uncertainty and related anxiety, stress, and frustration are central themes in living with 
21 PA.31,33,42,43 The identification and treatment of psychological issues impacting management, 
22 confidence, and quality of life should be seen as a priority and should be addressed by HCPs in 
23 coordination with governmental and nongovernmental organisations (such as PAGS). 
24
25 The APPEAL-1 study also presents evidence of the problem across Europe of low confidence (and 
26 knowledge) in how and when to use an AAI. Our findings are consistent with global data showing 
27 unmet patient needs for AAI use training and anaphylaxis management across food and nonfood 
28 allergens.44 Approximately one-third of respondents in the APPEAL-1 study were not “very 
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1 confident” in knowing when to use an AAI. These findings add value to previous findings. A 
2 qualitative single-center study, for example, found that among 17 participating parents of children 
3 with anaphylactic reactions to peanut, almost all said that, at diagnosis of their child’s PA, they had 
4 been given insufficient information on using an AAI.42 Respondents also reported that the general 
5 population (people outside their circle of family and friends) have a poor understanding of PA.
6
7 Although responses were consistent across countries with regard to the burden of peanut allergy on 
8 psychosocial issues, the study also demonstrated some cross-country differences regarding the weight 
9 and type of that impact. We note here that these differences are likely due to interactions or modifiers 
10 across variables. Here we presented only descriptive data. For example, respondents from Germany 
11 expressed the highest levels of restriction of choice in activities, yet also reported the lowest rate of 
12 frustration among the countries, suggesting that the relationship is modified by other variable(s) such 
13 as level of general awareness or acceptance. In other findings, results provide a clearer picture, for 
14 example, in the case of respondents from the Netherlands reporting the highest rate for positive 
15 coping skills and the lowest rate for anxiety and for “rarely feeling calm,” together with low levels of 
16 uncertainty and stress. 
17
18 The strengths of this study include the large sample size, inclusion of participants across 8 countries, 
19 the multidimensional nature of the factors measured at one time, scope, and the diversity of the 
20 respondent groups. APPEAL-1 also included a quantitative examination of some novel factors such as 
21 AAI training, which may have practical healthcare implications. Previous studies have reported 
22 differences in HRQL for food allergy among residents of different European countries.45,46 However, 
23 APPEAL-1 also identifies differences among the 8 participating European countries in areas of 
24 healthcare management of PA, which have not been previously reported and are of key importance 
25 (See companion paper in this issue of Allergy). 
26
27 We acknowledge also the limitations of our design. The APPEAL-1 study findings may be negatively 
28 impacted by biases related to the self-selection recruitment methods. For example, individuals 
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1 greatest impact, while those who feel less affected might be less likely to participate. Potential biases 
2 might also have been associated with each of the 2 recruitment methods used: respondents recruited 
3 through a PAG may have been more motivated to participate for emotional reasons related to PA 
4 while those who participated through the recruitment service may have been more motivated by 
5 incentive (since financial remuneration was offered). Other limitations include the absence of 
6 randomisation, and use of self- or proxy-reported data. 
7
8 APPEAL-1 is the first multidimensional, pan-European online survey study specifically designed to 
9 uncover the psychosocial burden of PA on the lives of both PwPA and their families. The findings 
10 showed a strong burden of PA on emotional and psychosocial functioning in children, adults, and 
11 caregivers. The APPEAL-1 findings deepen our knowledge and understanding of the impact of PA on 
12 everyday lives, and show the importance of raising PA awareness in the general public, increasing 
13 support for managing this condition, and supporting inclusivity of those with PA. The study also 
14 underscores the unmet needs, such as unsatisfactory training for AAI use and low confidence among 
15 PwPA who use AAIs, and provides some signposts for clinicians and policymakers on how these may 
16 be addressed. Addressing psychosocial issues and constraints that impact management, confidence, 
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13 Figure Legends  
14   
15 Figure 1 Restrictions on choice: responses to question: “How RESTRICTED do you feel…” 
16 (N=1846: all respondents)  
17 NA, not applicable.  
18   
19 Figure 2 Responses to question: “Do you think you have ever been excluded from the following 
20 because of your peanut allergy?” (N=1300: all participants [adults with PA and caregivers answering 
21 for themselves])  
22 NA, not applicable  
23   
24 Figure 3 Responses to questions: A. “How would you describe the impact ON YOU of the bullying?” 
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1 CHILD/THE PERSON YOU LOOK AFTER of the bullying?” (n=395: caregivers who said their 
2 child had been bullied)  
3   
4 Figure 4 Responses to question: “How well would you say you cope with your peanut allergy now 
5 compared to when it was FIRST identified/diagnosed?” (N=1846: all respondents)  
6   
7 Figure 5 Responses to question: “Thinking about your FAMILY/FRIENDS/OTHER PEOPLE: please 
8 rank the following statements in terms of what you think is most true about what they believe.” 
9 (1=most true, 5=least true)  
10   
11 Figure 6 Discussing the impact of living with peanut allergy: responses to the question: “Do you find 
12 it easy to openly discuss the impact of living with peanut allergy with family, friends, healthcare 
13 professionals, school teachers, and work colleagues?” (N=1846: all respondents)a  
14 aBecause of rounding, not all bars total 100%.  





















































































When travelling on public transport (e.g. trains, buses, taxis)
About the job options available to you
About the choice of Nursery / Schools / University available to you to attend
When choosing the shops where you can buy food (e.g. places where you feel it is...
When socialising with friends and colleagues
About travelling on aeroplanes
About the choice of holiday destination venues where you feel it is safe to go to
When buying food from a shop (e.g. peanut free choices available when food...
About the types of holiday available where you feel it is safe to go (e.g. Summer...
When going to special occasions such as birthday parties and social gatherings
When choosing where to eat out (e.g. the places available where feel it is safe to...
About the food you can choose when eating out (e.g. the choice of food available...
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food is involved (e.g. 
eating out)
Social occasions where 
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TABLE
TABLE 1 In the words of survey respondents: impacts of peanut allergy on psychosocial parameters 
(free-text responses)
Quote 1: My daughter avoids any foods if she is unsure they are safe, e.g. homemade cakes and 
biscuits, chocolate etc. We all carefully read packets whether it is at home or abroad and I now 
know the word for peanut and peanut oil etc in many different European languages so we can 
keep our daughter safe when we travel. However, I would not be happy to travel to Asia because 
of her allergy.
Quote 2: I don't like to go out with my friends as I never know where I can eat if it is a last-
minute decision. I’m also concerned in case a boy has eaten peanuts and I don't know it and I 
kiss him.
Quote 3: I have always had 2 rules: 1) Plan ahead, be firm and avoid nuts as far as possible, 
have EpiPen always, get son's friends to know what to do, have a care plan; and 2) See rule 1.
Quote 4: I do find it annoying that restaurants like to “cop out.” They say, “We can't guarantee 
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watched as my daughter tries to handle waiters but they can be dismissive of a teenager who 
might then not eat with her friends. If adults are around, staff seem to be more helpful.
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